Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
June 18, 2010Journal of Cardiovascular Pharmacology and Therapeutics

Review: Optimizing the Management of Atrial Fibrillation: Focus on Current Guidelines and the Impact of New Agents on Future Recommendations

View Full Paper
Ask AI
Bookmark
Share

Population

Patients with atrial fibrillation

Design

Review

Authors

GNGerald V. NaccarelliElectrophysiologyACAnne B. CurtisElectrophysiology

Discussion

Loading...

Member takes

Overview

Supports individualized AF strategies per guidelines; extends reviews on emerging agents but leaves comparative efficacy open.

Structured PICO

P
Population
Patients with atrial fibrillation
I
Intervention
Pharmacologic options and new agents for atrial fibrillation management

A review emphasizing the individualization of atrial fibrillation treatment using current guidelines and emerging pharmacologic agents.

Cite This Study

Naccarelli et al. (2010) studied this question.

synapsesocial.com/papers/6a221b99e8ef4064f24ebebbhttps://doi.org/10.1177/1074248410370964
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study2004 · 1,219 citations
  2. 2Electrical, contractile and structural remodeling during atrial fibrillation2002 · 1,462 citations
  3. 3Long-Term Progression and Outcomes With Aging in Patients With Lone Atrial Fibrillation2007 · 406 citations
  4. 4Why does atrial fibrillation occur?1997 · 85 citations
  5. 5Primary Prevention of Ischemic Stroke2006 · 1,372 citations